GAA and metabolic myopathy: An exemplary study on Pompe disease, a metabolic myopathy, demonstrated that approximately one-third of dysregulated proteins are restored when the enzyme acidic alpha-glucosidase (GAA), missing in the patients due to genetic mutations, is restored, thereby identifying molecular targets to improve patient outcomes [39].